ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
19 announcements with these filters
Tavexia Lifecare Ltd board approved changing its RTA from Niche Technologies to Skyline Financial Services. Niche continues until data transition and depository confirmations are complete.
Sattva Sukun Lifecare Ltd reported revenue from operations of ₹5 Cr (-70.2% YoY) and a net loss of ₹0.4 Cr for Q2 FY27.
Tavexia Lifecare has scheduled a board meeting for November 4, 2026 to consider Q2 results, RTA change, and a fund-raise proposal. All items are proposed only.
Tavexia Lifecare Ltd submitted its quarterly shareholding pattern report for the period ended September 30, 2026, in compliance with SEBI regulations.
Tavexia Lifecare will acquire a 60% stake in Meyonex Pharmaceuticals Limited for ₹67.19 Crore. This strategic investment aims to expand its pharmaceutical sector presence.
Tavexia Lifecare Limited concluded its 46th Annual General Meeting on September 30, 2026. Shareholders approved the financial statements, auditor appointment, related party transactions, and director re-appointment.
Promoter group entity Roshan Dealmark Private Limited sold 2,50,000 equity shares of Tavexia Lifecare Ltd via market sale.
Tavexia Lifecare will hold a board meeting on October 7, 2026, to discuss the proposed acquisition of Meyonex Pharmaceuticals and approve the half-yearly financial results.
Roshan Dealmark Private Limited (Promoter Group) sold 700,000 equity shares of Tavexia Lifecare Ltd via market sale on September 25, 2026.
Promoter Group entity, Roshan Dealmark Private Limited, sold 2,00,000 shares of Tavexia Lifecare Ltd in the open market, aggregating to ₹0.02 Crore.
Promoter group entity Roshan Dealership Private Limited sold 4,00,000 Tavexia Lifecare shares on BSE for ₹0.05 Crore. Stake reduced from 4.03% to 3.93%.
Promoter Roshan Dealmark Pvt Ltd sold 4,00,000 Tavexia Lifecare shares on-market on 23.09.2026. Its stake fell from 4.051% to 3.947%, a 0.104% reduction.
Roshan Dealmark, a promoter group entity, sold 9,07,105 shares of Tavexia Lifecare on BSE for Rs. 0.11 Crore. Stake reduced from 4.27% to 4.03%.
Roshan Dealmark Private Limited (Promoter Group) sold 2,80,000 equity shares of Tavexia Lifecare Ltd through a market sale on the BSE. The transaction value was ₹0.03 Crore.
Roshan Dealmark Private Limited, part of the Promoter Group, sold 10 lakh shares of Tavexia Lifecare Ltd for ₹0.12 Crore via market sale.
Promoter Group entity Roshan Dealmark Private Limited sold 8,01,878 equity shares of Tavexia Lifecare Ltd via market sale on BSE, reducing its stake by 0.21%.
Roshan Dealmark, a promoter, disposed 14,00,000 Tavexia Lifecare shares on-market on 15 Sep 2026, cutting its stake from 5.19% to 4.83%.
Promoter group entity Roshan Dealmark sold 18 lakh shares of Tavexia Lifecare via market sale. The sale reduces the promoter's stake by 0.47%.
Roshan Dealmark Private Limited (Promoter Group) sold 14,00,000 equity shares of Tavexia Lifecare Ltd for ₹0.16 Crore via an open market transaction.